Literature DB >> 16943422

Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Nicolas Venteclef1, Jason C Smith, Bryan Goodwin, Philippe Delerive.   

Abstract

The orphan nuclear receptor liver receptor homolog 1 (LRH-1) has been reported to play an important role in bile acid biosynthesis and reverse cholesterol transport. Here, we show that LRH-1 is a key player in the control of the hepatic acute-phase response. Ectopic expression of LRH-1 with adenovirus resulted in strong inhibition of both interleukin-6 (IL-6)- and IL-1beta-stimulated haptoglobin, serum amyloid A, and fibrinogen beta gene expression in hepatocytes. Furthermore, induction of the hepatic inflammatory response was significantly exacerbated in HepG2 cells expressing short hairpin RNA targeting LRH-1 expression. Moreover, transient-transfection experiments and electrophoretic mobility shift and chromatin immunoprecipitation assays revealed that LRH-1 regulates this cytokine-elicited inflammatory response by, at least in part, antagonizing the CCAAT/enhancer binding protein beta signaling pathway. Finally, we show, by using LRH-1 heterozygous mice, that LRH-1 is involved in the control of the inflammatory response at the hepatic level in vivo. Taken together, our results outline an unexpected role for LRH-1 in the modulation of the hepatic acute-phase response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943422      PMCID: PMC1592867          DOI: 10.1128/MCB.00579-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

Review 1.  Cytokines in the liver.

Authors:  G Ramadori; T Armbrust
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 2.566

2.  Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha -hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription.

Authors:  A del Castillo-Olivares; G Gil
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

Review 3.  Transcriptional control mechanism of fibrinogen gene expression.

Authors:  G M Fuller; Z Zhang
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

Review 4.  Peroxisome proliferator-activated receptors in inflammation control.

Authors:  P Delerive; J C Fruchart; B Staels
Journal:  J Endocrinol       Date:  2001-06       Impact factor: 4.286

5.  Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes.

Authors:  Colin D Clyne; Caroline J Speed; Jiong Zhou; Evan R Simpson
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

Review 6.  Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.

Authors:  G Chinetti; J C Fruchart; B Staels
Journal:  Inflamm Res       Date:  2000-10       Impact factor: 4.575

7.  The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor.

Authors:  Y Luo; C P Liang; A R Tall
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

8.  High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.

Authors:  B J Van Lenten; A C Wagner; D P Nayak; S Hama; M Navab; A M Fogelman
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

9.  Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation.

Authors:  Jinyong Kim; Carrie A Cantwell; Peter F Johnson; Curt M Pfarr; Simon C Williams
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

10.  The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms.

Authors:  D P Ramji; A Vitelli; F Tronche; R Cortese; G Ciliberto
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

View more
  15 in total

Review 1.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

2.  LRH-1-dependent glucose sensing determines intermediary metabolism in liver.

Authors:  Maaike H Oosterveer; Chikage Mataki; Hiroyasu Yamamoto; Taoufiq Harach; Norman Moullan; Theo H van Dijk; Eduard Ayuso; Fatima Bosch; Catherine Postic; Albert K Groen; Johan Auwerx; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

3.  LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease.

Authors:  Agnes Coste; Laurent Dubuquoy; Romain Barnouin; Jean-Sebastien Annicotte; Benjamin Magnier; Mario Notti; Nadia Corazza; Maria Cristina Antal; Daniel Metzger; Pierre Desreumaux; Thomas Brunner; Johan Auwerx; Kristina Schoonjans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

4.  A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring.

Authors:  Stéphanie A Bayol; Bigboy H Simbi; Robert C Fowkes; Neil C Stickland
Journal:  Endocrinology       Date:  2010-03-05       Impact factor: 4.736

5.  GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response.

Authors:  Nicolas Venteclef; Tomas Jakobsson; Anna Ehrlund; Anastasios Damdimopoulos; Laura Mikkonen; Ewa Ellis; Lisa-Mari Nilsson; Paolo Parini; Olli A Jänne; Jan-Ake Gustafsson; Knut R Steffensen; Eckardt Treuter
Journal:  Genes Dev       Date:  2010-02-15       Impact factor: 11.361

6.  Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).

Authors:  Richard J Whitby; Jozef Stec; Raymond D Blind; Sally Dixon; Lisa M Leesnitzer; Lisa A Orband-Miller; Shawn P Williams; Timothy M Willson; Robert Xu; William J Zuercher; Fang Cai; Holly A Ingraham
Journal:  J Med Chem       Date:  2011-03-10       Impact factor: 7.446

7.  Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists.

Authors:  Suzanne G Mays; C Denise Okafor; Richard J Whitby; Devrishi Goswami; Józef Stec; Autumn R Flynn; Michael C Dugan; Nathan T Jui; Patrick R Griffin; Eric A Ortlund
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

8.  Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Meihua Wang; Donna Yu; Barry M Forman; Wendong Huang
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

9.  Liver receptor homolog-1 is a critical determinant of methyl-pool metabolism.

Authors:  Martin Wagner; Sungwoo Choi; Katrin Panzitt; Jennifer L Mamrosh; Jae Man Lee; Alex Zaufel; Rui Xiao; Ruth Wooton-Kee; Marcus Ståhlman; Christopher B Newgard; Jan Borén; David D Moore
Journal:  Hepatology       Date:  2015-10-10       Impact factor: 17.425

10.  Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease.

Authors:  Sokrates Stein; Vera Lemos; Pan Xu; Hadrien Demagny; Xu Wang; Dongryeol Ryu; Veronica Jimenez; Fatima Bosch; Thomas F Lüscher; Maaike H Oosterveer; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.